Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00372 | SPDP | 68181-17-9 |
| Inquiry | ||
| BADC-01986 | 1-Amino-8-azido-3,6-dioxaoctane tosylate | 2173092-98-1 |
| Inquiry | ||
| BADC-01928 | cis-4-Hydroxy-D-proline HCl | 77449-94-6 |
| cis-4-Hydroxy-D-proline HCl is a non-cleavable ADC linker and also an alkyl chain-based PROTAC linker. | Inquiry | |
| BADC-00506 | GMBS | 80307-12-6 |
| GMBS is a non-cleavable linker widely used in antibody-drug conjugation development. Its unparalleled efficacy stems from its chemical cross-linking ability, promoting the covalent binding of proteins, peptides, antibodies and countless other molecules. Notably, GMBS occupies a key position in the fields of drug delivery systems, diagnostics, and evolving bioconjugation technologies. | Inquiry | |
| BADC-01163 | DTSSP Crosslinker | 81069-02-5 |
| Inquiry | ||
| BADC-01972 | 8-Azido-3,6-dioxaoctanoyl-AEEA | 1254054-60-8 |
| Inquiry | ||
| BADC-01541 | 3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol | 3055-99-0 |
| 3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol is a linker widely used in antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01964 | Azido palmitic acid | 118162-46-2 |
| Inquiry | ||
| BADC-01527 | 6-Azido-hexylamine | 349553-73-7 |
| 6-Azido-hexylamine is a highly versatile cleavable linker widely used in biomedical fields. This compound is known for its key role in advancing targeted therapeutic release mechanisms and bioconjugation approaches that can significantly enhance the ability to fight a range of diseases including cancer, infectious diseases and neurological diseases. | Inquiry | |
| BADC-00964 | Aminoethyl-SS-propionic acid | 15579-00-7 |
| Inquiry | ||
| BADC-01190 | N-Bromoacetyl-β-alanine | 89520-11-6 |
| N-Bromoacetyl-β-alanine is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs. N-Bromoacetyl-β-alanine is also a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01131 | Maleimido-tri(ethylene glycol)-propionic acid | 518044-40-1 |
| Maleimido-tri(ethylene glycol)-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Maleimido-tri(ethylene glycol)-propionic acid is used for the preparation of neolymphostin-based ADC precursors for site-specific cysteine mutant trastuzumab-A114C conjugation. | Inquiry | |
| BADC-00597 | Sulfo-SIAB sodium | 144650-93-1 |
| Sulfo-SIAB sodium is a nonclaevable monovalent bilinker. | Inquiry | |
| BADC-00985 | Sulfo-SPDP-C6-NHS sodium | 169751-10-4 |
| Inquiry | ||
| BADC-00507 | N-Hydroxysuccinimidyl-4-azidobenzoate | 53053-08-0 |
| N-Hydroxysuccinimidyl-4-azidobenzoate is a non-cleavable linker in the field of antibody drug conjugation and has been widely used in the field of bioconjugation and cross-linking. Its key role is to facilitate the development of targeted drug delivery systems and diagnostic tools of paramount importance. By creating covalent bonds between biomolecules and multiple agents or interfaces, it provides a way to precisely target and manage diseases such as cancer, autoimmune abnormalities, and infectious diseases. | Inquiry | |
| BADC-00501 | Mc-Val-Cit-PABC-PNP | 159857-81-5 |
| Inquiry | ||
| BADC-01135 | Fmoc-N-amido-PEG4-propionic acid | 557756-85-1 |
| Fmoc-NH-PEG4-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01930 | (4S)-4-Hydroxy-L-proline hydrochloride | 441067-49-8 |
| (4S)-4-Hydroxy-L-proline hydrochloride is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01925 | 1-BOC-Azetidine-3-carboxylic acid methyl ester | 610791-05-4 |
| 1-BOC-Azetidine-3-carboxylic acid methyl ester is a non-cleavable ADC linker and also an alkyl chain-based PROTAC linker. | Inquiry | |
| BADC-01546 | 2,5-Dioxopyrrolidin-1-yl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate | 64191-06-6 |
| 2,5-Dioxopyrrolidin-1-yl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate is a linker widely used in antibody-drug conjugates (ADCs). | Inquiry |
